BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15583463)

  • 1. Clinicopathological features influencing pelvic lymph node metastasis and vaginal and parametrial involvement in patients with carcinoma of the cervix.
    Silva-Filho AL; Reis FM; Traiman P; Pedrosa MS; Miranda D; Triginelli SA
    Gynecol Obstet Invest; 2005; 59(2):92-6. PubMed ID: 15583463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
    Santos-Filho AS; Triginelli SA; Traiman P; Cunha-Melo JR; Silva-Filho AL
    Arch Gynecol Obstet; 2007 Jan; 275(1):13-7. PubMed ID: 16858573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological and immunohistochemical (cytokeratins AE1/AE3) study of the parametrium of patients with early stage cervical cancer.
    Cândido EB; Silva-Filho AL; Triginelli SA; Pedrosa MS; Macarenco R; Porto L; Traiman P
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):58-63. PubMed ID: 18938023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
    Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
    Tian QF; Wang XY; Lü WG; Ye F; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.
    Chandacham A; Charoenkwan K; Siriaunkgul S; Srisomboon J; Suprasert P; Phongnarisorn C; Cheewakraingkrai C; Siriaree S; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S31-6. PubMed ID: 17722314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How important is removal of the parametrium at surgery for carcinoma of the cervix?
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between CD31 expression and histopathologic features in stage IB squamous cell carcinoma of the cervix.
    Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco R; Cunha-Melo JR
    Int J Gynecol Cancer; 2006; 16(2):757-62. PubMed ID: 16681757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical-pathologic risk factors and immunohistochemical markers of pelvic lymph node metastasis in stage IB1 cervical cancer.
    Hernandez E; De La Mota J; Thomas MB; Huang Y; Gaughan JP; Wang F
    J Low Genit Tract Dis; 2011 Oct; 15(4):303-8. PubMed ID: 21811179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cervical cancer and parametrial involvement: is it significant?
    Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
    Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
    Reich O; Tamussino K; Lahousen M; Pickel H; Haas J; Winter R
    Gynecol Oncol; 2000 Mar; 76(3):331-5. PubMed ID: 10684706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
    Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
    Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
    Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.